Stockreport

Neurocrine Biosciences: Expanding Opportunities, 2026 Will Be Less Exciting [Seeking Alpha]

Neurocrine Biosciences, Inc.  (NBIX) 
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations
PDF for 2026 was in-line with published expectations but arguably a bit lackluster. NBIX's pipeline is deepening, but meaningful clinical catalysts are unlikely before 202 [Read more]